Compare Globus Medical Inc. Class A Common Stock (GMED) vs ServiceNow Inc (NOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs ServiceNow Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while ServiceNow Inc trades at $139.6 (market cap $144.72B). The key difference: ServiceNow Inc is far larger — about 14.1× Globus Medical Inc. Class A Common Stock's market cap, and ServiceNow Inc is more actively traded (13,299,981 versus 1,059,528). Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and ServiceNow Inc for 54 Days on average.
| GMED | NOW | |
|---|---|---|
Market Cap | $10.25B | $144.72B |
Volume | 1,059,528 | 13,299,981 |
Sector | Health | Technology |
52-Week High | $96.82 | $189.26 |
52-Week Low | $58.33 | $83.00 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $9.76B | $148.51B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
ServiceNow (NOW) trades at $138.61, down 1.22% on the day, amid a bullish technical setup with strong analyst support. The stock shows robust fundamentals with revenue growth from $7.2B in 2022 to $13.3B in 2025, a high gross margin of 74.77%, and consistent earnings beats. Recent news highlights AI-driven momentum, with AI annual contract value surpassing $1B in Q2 2026, fueling positive sentiment despite premium valuations.
The outlook remains positive given AI adoption and earnings strength, but risks include stiff competition and high P/E of 86.63. With 87% of analysts rating it Buy and a consensus target of $150.74, the stock offers upside, though investors should weigh valuation concerns against growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About ServiceNow Inc
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →
